SteadyMD Report Identifies 3 Trends That Will Shape Healthcare Landscape in 2024

Clinician shortages, telehealth demand and GLP-1 treatment will require innovative technology solutions ST. LOUIS, Dec. 7, 2023 /PRNewswire/ — Three care access and operational challenges confronting traditional and digital healthcare delivery models will intensify in 2024, but can be alleviated by embracing disruptive technology and strategic telehealth partnerships that ease clinician burden and ensure patients… Continue reading SteadyMD Report Identifies 3 Trends That Will Shape Healthcare Landscape in 2024

Parks Associates: 20% of US Internet Households Own a Television Antenna, and 12% Plan to Buy One

Industry report presents a focused analysis of the impact of ATSC 3.0 on the video market DALLAS, Dec. 7, 2023 /PRNewswire/ — Parks Associates, the premier technology research firm, recently released the industry report “ATSC 3.0: Impact and Opportunity for Video Services,” which reveals that 20% of US internet households own a television antenna and 12%… Continue reading Parks Associates: 20% of US Internet Households Own a Television Antenna, and 12% Plan to Buy One

HARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT IN ADULT PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1

PLYMOUTH MEETING, Pa., Dec. 7, 2023 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (“Harmony” or the “Company”) (Nasdaq: HRMY) today announced positive topline results from its Phase 2 signal detection study evaluating the safety and efficacy of pitolisant in adult patients with myotonic dystrophy type 1 (DM1). A clinically meaningful improvement was demonstrated on the primary… Continue reading HARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT IN ADULT PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1

Genpact Strengthens Executive Team with Leadership Appointments for Investor Relations and Marketing

Company names Krista Bessinger as Head of Investor Relations and Caitlin Blewett as Chief Marketing Officer, bolstering Genpact’s growth agenda centered around data, technology, and AI NEW YORK, Dec. 7, 2023 /PRNewswire/ — Genpact (NYSE: G), a global professional services firm focused on delivering outcomes that transform businesses, announced the following appointments to its executive team:… Continue reading Genpact Strengthens Executive Team with Leadership Appointments for Investor Relations and Marketing

@Ford: Ford and Resideo Launch ‘EV-Home Power Partnership’ Project Driving Vehicle-to-Home Energy Management Benefits for Customers

Ford and Resideo are exploring new areas of value for customers who own an F-150 Lightning and a Resideo smart thermostat to help enable potential monthly electric bill savings, increased comfort and more efficient home energy use This first-of-its-kind collaboration between Ford and Resideo builds on Ford’s Intelligent Backup Power technology to explore customer benefits… Continue reading @Ford: Ford and Resideo Launch ‘EV-Home Power Partnership’ Project Driving Vehicle-to-Home Energy Management Benefits for Customers

VanWest Partners Announces Self Storage Development Project in Denver, CO

DENVER, Dec. 7, 2023 /PRNewswire/ — VanWest Partners (VanWest), a Denver-based commercial real estate investment firm specializing in self storage, recently broke ground on a self storage development project at 2425 S. Colorado Boulevard in Denver, Colorado. When construction is completed, the project will be operated by the firm’s wholly owned self storage management company, ClearHome Self… Continue reading VanWest Partners Announces Self Storage Development Project in Denver, CO

WILLOW AND LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY ADVANCE DEVELOPMENT PROGRAM TO MANUFACTURE SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS

Program brings immediate R&D revenue and first commercial supply revenue as early as 2024 Program further validates Willow’s BioOxi™ technology and focus on commercial execution and aligns with its strategic focus on near term revenue generation SUNNYVALE, Calif., Dec. 7, 2023 /PRNewswire/ – Willow Biosciences Inc. (“Willow”) (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing… Continue reading WILLOW AND LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY ADVANCE DEVELOPMENT PROGRAM TO MANUFACTURE SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS

Trident/Stitch Awarded 3 Solar Construction Projects Totaling 27MWdc

HOUSTON, Dec. 7, 2023 /PRNewswire/ — We are thrilled to announce the award of three Solar Construction Projects for a Prominent Energy Company totaling approximately 27MWdc. Trident EPC and Stitch Solutions, in a joint partnership dedicated to delivering energy infrastructure projects in North America by providing Engineering, Procurement and Construction for turnkey projects in Renewable… Continue reading Trident/Stitch Awarded 3 Solar Construction Projects Totaling 27MWdc

Asia-Pacific Nucleic Acid Therapeutics CDMO Market Report 2023: Pharmaceutical Firms Becoming More Outsourcing-Oriented – Opportunity Forecasts to 2033

DUBLIN, Dec. 7, 2023 /PRNewswire/ — The “Asia-Pacific Nucleic Acid Therapeutics CDMO Market – Analysis and Forecast, 2023-2033” report has been added to  ResearchAndMarkets.com’s offering. The APAC Nucleic Acid Therapeutics CDMO Market is expected to grow at a CAGR of 13.92% from $0.97 billion in 2022 to $4.04 billion by 2033 in the forecasted period… Continue reading Asia-Pacific Nucleic Acid Therapeutics CDMO Market Report 2023: Pharmaceutical Firms Becoming More Outsourcing-Oriented – Opportunity Forecasts to 2033

Ping An of China CSI HK Dividend ETF(3070.HK)Won Yinghua Award*

HONG KONG, Dec. 7, 2023 /PRNewswire/ — The Yinghua Awards (Overseas Funds), hosted by China Fund News, were announced on 5 December. Ping An of China CSI HK Dividend ETF(3070.HK) (the “HK Dividend ETF”), managed by Ping An of China Asset Management (Hong Kong) Company Limited (“PAAMC HK”), the offshore asset management arm of Ping An Insurance… Continue reading Ping An of China CSI HK Dividend ETF(3070.HK)Won Yinghua Award*